- KR₩1tn
- KR₩1tn
- KR₩829bn
- 58
- 41
- 95
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.37 | ||
| PEG Ratio (f) | 0.46 | ||
| EPS Growth (f) | 40.98% | ||
| Dividend Yield (f) | 0.87% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.92 | ||
| Price to Tang. Book | 8.7 | ||
| Price to Free Cashflow | 25.25 | ||
| Price to Sales | 1.34 | ||
| EV to EBITDA | 14.29 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.84% | ||
| Return on Equity | 3.99% | ||
| Operating Margin | 7.31% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 539,907.69 | 598,446.72 | 769,785.56 | 846,521.7 | 828,908.23 | 924,737 | 986,672 | 19.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +154.48 | -14.08 | +38.03 | +30.95 | +50.46 | +27.79 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HK Inno.N Corp is a Korea-based company mainly engaged in the manufacture and sale of prescription drugs. The Company operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The Company sells its products within domestic market and to overseas markets.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 1st, 2014
- Public Since
- August 9th, 2021
- No. of Shareholders
- 128,247
- No. of Employees
- 1,709
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 28,329,891
- Address
- 6-8F, CHUNGJU, 28158
- Web
- http://www.inno-n.com/
- Phone
- +82 264770000
- Auditors
- Ernst & Young Han Young
Upcoming Events for 195940
Similar to 195940
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
Ahn-Gook Pharmaceutical Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:10 UTC, shares in HK inno.N are trading at KR₩39,150. This share price information is delayed by 15 minutes.
Shares in HK inno.N last closed at KR₩39,150 and the price had moved by +19.6% over the past 365 days. In terms of relative price strength the HK inno.N share price has outperformed the FTSE Developed Asia Pacific Index by +19.72% over the past year.
The overall consensus recommendation for HK inno.N is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The HK inno.N dividend yield is 0.89% based on the trailing twelve month period.
Last year, HK inno.N paid a total dividend of KR₩350, and it currently has a trailing dividend yield of 0.89%.Looking ahead, the next dividend pay date is 2024-04-26.
We do not have data on when HK inno.N is to next pay dividends. The historic dividend yield on HK inno.N shares is currently 0.89%.
To buy shares in HK inno.N you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩39,150, shares in HK inno.N had a market capitalisation of KR₩1tn.
Here are the trading details for HK inno.N:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 195940
Based on an overall assessment of its quality, value and momentum HK inno.N is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in HK inno.N is KR₩56,364. That is 43.97% above the last closing price of KR₩39,150.
Analysts covering HK inno.N currently have a consensus Earnings Per Share (EPS) forecast of KR₩2,686 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HK inno.N. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -17.37%.
As of the last closing price of KR₩39,150, shares in HK inno.N were trading +0.5% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The HK inno.N PE ratio based on its reported earnings over the past 12 months is 13.37. The shares last closed at KR₩39,150.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
HK inno.N's management team is headed by:
- Dal Won Gwak - CEO